Dow's 190-point Climb Highlighted By Gains For Shares Of Merck, Johnson & Johnson

Johnson & Johnson

Change company Symbol lookup

Select an option...

JNJ Johnson & Johnson

FRSHY China Jinmao Holdings Group Ltd

EQH-C Equitable Holdings Inc

IBTX Independent Bank Group Inc

DLTR Dollar Tree Inc

FRTX Fresh Tracks Therapeutics Inc

PLXS Plexus Corp

YEXT Yext Inc

UPWK Upwork Inc

NEGG Newegg Commerce Inc

Health Care : Pharmaceuticals | Large Cap Blend

Company profile

Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Dow's 190-point Climb Highlighted By Gains For Shares Of Merck, Johnson & Johnson

1:26 pm ET November 14, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Powered by strong returns for shares of Merck and Johnson & Johnson, the Dow Jones Industrial Average is trading up Monday afternoon. The Dow is trading 190 points (0.6%) higher, as shares of Merck (MRK) and Johnson & Johnson (JNJ) are contributing to the index's intraday rally. Merck's shares have climbed $3.68 (3.8%) while those of Johnson & Johnson have gained $3.81 (2.3%), combining for an approximately 49-point bump for the Dow. Also contributing significantly to the gain are IBM (IBM), Travelers (TRV), and Visa (V). A $1 move in any of the benchmark's 30 components results in a 6.59-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2022.

(END) Dow Jones Newswires

November 14, 2022 13:26 ET (18:26 GMT)